Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

799 results about "Molecule docking" patented technology

Screening and preparation method and application of horse milk whey protein source antioxidant peptide

The invention relates to a method for screening and preparing a horse milk whey protein source antioxidant peptide and application of the horse milk whey protein source antioxidant peptide. The polypeptide with potential antioxidant activity is screened out by predicting information of the polypeptide through virtual enzymolysis and a computer and then performing molecular docking with the keap1 protein. The feasibility of obtaining the antioxidant peptide is verified by simulating gastrointestinal digestion with pepsin, trypsin and chymotrypsin. Finally, in-vitro chemical antioxidant activity verification is carried out through chemical synthesis of the high-purity antioxidant peptide, and it is found that the antioxidant peptide has good free radical scavenging activity. An oxidative damage model is induced by H2O2 on cells, and it is found that the antioxidant peptide can resist cell oxidative damage by exciting the activity of a series of antioxidant enzymes. The natural antioxidant peptide screened by the invention has wide application prospects in the fields of foods, medicines, cosmetics and the like, and an efficient way is provided for development of horse milk whey protein source functional polypeptide products.
Owner:CHINA AGRI UNIV

Sea cucumber gonad-derived antioxidant peptide as well as preparation method and application thereof

The invention discloses sea cucumber gonad-derived antioxidant peptide as well as a preparation method and application thereof, and belongs to the technical field of food biology. The antioxidant peptide is obtained by carrying out enzymolysis and molecular docking screening on sea cucumber gonads, and comprises at least one of peptides with amino acid sequences as shown in SEQ.ID.NO.1-4. Wherein the docking energy of the SEQ.ID.NO.1 and the receptor SOD is-7.5 kcal / mol, the docking energy of the SEQ.ID.NO.2 and the receptor SOD is-7.5 kcal / mol, the docking energy of the SEQ.ID.NO.3 and the receptor SOD is-7.4 kcal / mol, and the docking energy of the SEQ.ID.NO.4 and the receptor SOD is-7.2 kcal / mol. Tests prove that the antioxidant peptide has high antioxidant activity and has wide application space in the field of functional food.
Owner:LUDONG UNIVERSITY

Enzyme modification method based on artificial intelligence

The invention provides an enzyme modification method based on artificial intelligence. The enzyme modification method comprises the following steps: training an AlphaFold2 model to obtain a glycosyltransferase tertiary structure prediction model; performing multi-sequence comparison on the protein and nucleic acid sequence database and the non-redundant protein feature sequence database based on the active point location recognition model to obtain a comparison result; initializing a matrix of which the length is equal to that of a comparison result, so as to construct a PSSM matrix and screen out potential mutation sites; according to the screened potential mutation sites, constructing an initial mutation library to form a virtual screening mutation library; performing structure reconstruction on the sequence in the virtual screening mutation library based on a glycosyl transferase tertiary structure prediction model so as to predict the glycosyl transferase tertiary structure and perform molecular docking and dynamic simulation on the glycosyl transferase tertiary structure; the method is used for analyzing binding pockets of proteins and ligands and determining dynamic interaction of amino acid residues and ligands in the binding pockets, and the contact number of each amino acid residue and the ligands is used for modifying the tertiary structure of the glycosyltransferase.
Owner:BEIJING QINGKE BIOTECHNOLOGY CO LTD

Virtual screening method for candidate drugs

The invention discloses a virtual screening method of candidate drugs. The virtual screening method comprises the following steps: 1) providing an FXR receptor; providing a TGR5 receptor; oCA with a modified structure is used as a lead compound; providing an FXR ligand small molecule; 2) according to an active pocket of the FXR, performing molecular docking scoring on the lead compounds and the FXR, and screening the lead compounds to obtain a first compound; 3) according to an active pocket of the TGR5 receptor, performing molecular docking scoring on each first compound and the TGR5 receptor, and screening out a second compound from the first compounds; and 4) screening the second compound by adopting a pharmacophore model constructed on the basis of FXR ligand small molecules. The method provided by the invention can effectively reduce blindness of traditional drug design experiments, has high efficiency and low cost, can greatly reduce the time required for improving the compound, and increases the success rate. The candidate drug can regulate lipid metabolism and has no side effect.
Owner:WUHAN UNIV OF SCI & TECH

Sturgeon ovary active peptide with ovary senescence resistance and preparation method of sturgeon ovary active peptide

The invention discloses sturgeon ovary active peptide with ovary aging resistance and a preparation method of the sturgeon ovary active peptide. According to the invention, sturgeon ovary is taken as a raw material, and peptide with the highest ovarian aging resistance activity is selected from different enzymolysis combinations through an in-vitro anti-oxidation test and an ovarian granular cell and caenorhabditis elegans test; three sturgeon ovary active peptide sequences with ovary senescence resistance activity are screened by virtue of bioinformatics technologies such as mass spectrum identification, molecular docking and the like, and the amino acid sequences of the sturgeon ovary active peptide sequences are Phe-Met-Ile (FMI), Phe-Asp-Pro-Phe (FDPF) and Ser-Trp-Pro-Trp-Gln (SWPWQ). The sturgeon ovarian peptide prepared by the method not only has remarkable anti-premature ovarian failure activity and successfully solves the problem of high-valued utilization of sturgeon byproducts, but also can be used as a natural and efficient functional factor, is widely applied to functional products in the related fields of health care products, cosmetics, medicines and the like, and has a wide application prospect. And the method shows extremely wide market application prospects and huge economic values.
Owner:XIAMEN YUANZHIDAO BIOTECHNOLOGY CO LTD

Virtual screening method of small-molecule inhibitor targeting YTHDF1 protein

The invention belongs to the field of drug design, and particularly discloses a virtual screening method of a small-molecule inhibitor targeting YTHDF1 protein, which comprises the following steps: acquiring a YTHDF1 protein structure, and carrying out homologous modeling to generate various conformation proteins; small molecules combined with the YTHDF1 protein are obtained, bait molecules are generated, and ligand molecules are formed; a ligand molecule is in butt joint with a binding site on the YTHDF1, and the compound is characterized through PLEC fingerprints; the method comprises the following steps: constructing a specificity scoring function by using a machine learning algorithm, carrying out scoring screening on a compound to be screened and a compound butted with YTHDF1 molecules, carrying out affinity prediction, and screening out the small-molecule inhibitor targeting YTHDF1. According to the virtual screening method provided by the invention, the YTHDF1 targeting molecules with high affinity can be accurately screened on a large scale, candidate molecules are provided for research and development of medicines for treating YTHDF1 related diseases, and a foundation is laid for clinical tests and medicine optimization.
Owner:SHENZHEN UNIV

Lotus seed protein peptide with ACE inhibitory activity and application thereof

The invention discloses preparation and application of lotus seed protein peptide with ACE (angiotensin converting enzyme) inhibitory activity, and belongs to the technical field of food-borne active peptide development. According to the ACE inhibitory peptide WVPRYFPF and the preparation method thereof, the ACE inhibitory peptide is rapidly screened by utilizing a polypeptiomics and molecular docking technology, the defects of time consumption and labor consumption caused by step-by-step separation and purification are avoided, the obtained ACE inhibitory peptide WVPRYFPF has extremely high ACE inhibitory activity, IC50 of the ACE inhibitory peptide WVPRYFPF is 16.7 mu M, and the ACE inhibitory peptide WVPRYFPF can be used for assisting or replacing hypertension drugs. The lotus seed protein peptide disclosed by the invention has the characteristic of inhibiting ACE enzyme activity in vitro, and animal experiments prove that the protein peptide can also play a role in lowering blood pressure in a spontaneous hypertension rat (SHR).
Owner:JIANGNAN UNIV

Molecular modification method for glycosyltransferase based on artificial intelligence

The invention provides a molecular modification method for glycosyltransferase based on artificial intelligence. The method comprises the following steps: acquiring description information of enzyme mutants to form a basic data set; performing physicochemical property analysis on the basic data set to obtain an analysis result set; calculating the quantized value of the conservative degree of the mutation site and the quantized value of the influence degree of different mutations on the sequence so as to construct a position specificity scoring matrix; extracting a position specificity scoring value and a frequency from the scoring matrix, determining a functional section, and performing weighting processing; performing three-dimensional structure prediction and energy calculation based on the three-dimensional structure reconstruction model of the mutant to obtain an energy value; calculating an energy change value between the mutant and the wild type; performing molecular docking and dynamic simulation analysis on the mutant protein to obtain quantitative description of an interaction mode and strength and dynamic simulation characteristic data; and constructing a model training set to train a machine learning model for predicting the change of the enzyme activity of the mutant.
Owner:BEIJING QINGKE BIOTECHNOLOGY CO LTD

Application of SLC16A5 inhibitor in preparation of medicine for treating acute myeloid leukemia

The invention relates to the field of molecular targeted therapy, and discloses an application of an SLC16A5 (MCT6) small-molecule inhibitor MCT6-Ai7-2 in preparation of a medicine for treating acute myeloid leukemia (AML). The inhibitor takes an SLC16A5 protein structure predicted by Alphafold as a target spot, and is obtained through compound database screening, molecular docking and druggability optimization. An in-vitro experiment proves that MCT6-Ai7-2 can remarkably inhibit proliferation of AML cell lines such as U937 and MOLM-13, induce cell apoptosis and retard a cell cycle, has an inhibiting effect on a primary AML patient specimen and is relatively low in toxicity to normal cells; in-vivo experiments show that the compound is effective and has good safety in AML model mice. In addition, the MCT6-Ai7-2 and the vinca can be combined to synergistically enhance the inhibition effect on vinca drug-resistant cells, and by reducing the expression of anti-apoptotic protein MCL-1, the activation of pro-apoptotic factors BIM and tBID is promoted to play a role. The invention provides a novel targeting drug and strategy for treatment of AML (especially drug-resistant or recurrent patients).
Owner:THE FIRST HOSPITAL OF CHINA MEDICIAL UNIV

Method and system for re-scoring after docking based on ligand similarity and DTI

The invention relates to the technical field of computer-aided drug design, and particularly discloses a re-scoring method and system after docking based on ligand similarity and DTI, and the method comprises the steps: obtaining a target protein, and retrieving from a database to obtain a template pocket similar to a pocket of the target protein and a corresponding template protein; scoring the target ligand by using the eutectic ligand of the template protein to obtain a similarity score; the target ligand is a potential active ligand of the target protein; carrying out molecular docking on a target protein and a target ligand, obtaining a molecular map through docking conformation, inputting the molecular map into a map attention network, and calculating to obtain a classification result score; and adding the similarity score and the classification result score, and sorting the target ligands from high to low to obtain a re-scoring result. According to the method, the advantages of ligand similarity and drug-target interaction are combined, so that the enrichment capacity and prediction accuracy of docking virtual screening are improved.
Owner:TIANJIN BEIYUN TECH CO LTD

Sesame umami peptide with antioxidant activity and application thereof

PendingCN119708123APeptidesFood scienceAmino acidFood flavour enhancer
The invention discloses a sesame umami peptide with antioxidant activity and application thereof, the amino acid sequence of the sesame umami peptide is at least one of GFE (Gly-Phe-Glu), YMD (Tyr-Met-Asp) and RFT (Arg-Phe-Thr), and the sesame umami peptide belongs to the technical field of bioactive peptides. Three novel umami peptides are found and identified from sesame protein in combination with virtual enzymolysis, directional screening and molecular docking, sensory evaluation and electronic tongue analysis prove that the umami peptides GFE, YMD and RFT have good umami characteristics and have a good umami increasing effect on sodium glutamate, the umami threshold value is 0.07-0.36 mmol / L, and meanwhile, the three umami peptides all have antioxidant activity. The novel umami peptide is excavated from the sesame, the utilization value of sesame byproducts can be improved, the extracted umami peptide can also be used as a flavor enhancer or applied to preparation of the flavor enhancer, a new raw material basis is provided for development of the flavor enhancer, seasonings and functional food, and good application prospects and important application value are achieved.
Owner:WUHAN POLYTECHNIC UNIVERSITY +1

Milk-derived pentapeptide for promoting calcium mineral absorption and application thereof

ActiveCN120623307APeptide/protein ingredientsSkeletal disorderOD - Optical densitySkull bone
The invention belongs to the technical field of biology, and particularly relates to milk-derived pentapeptide for promoting calcium mineral absorption and application of the milk-derived pentapeptide. The CPP containing the high-activity peptide fragment is obtained by optimizing a process, and the influence of the CPP on mineral absorption is verified by utilizing a zebra fish model. Then, the pentapeptide GPFPI with calcium absorption promoting activity is screened out from the CPP in combination with peptidomics and a molecular docking technology, functional verification is carried out, it is found that the pentapeptide presents a dose-dependent trend on Ca < 2 + > transport, the Ca < 2 + > transport amount is remarkably increased by 23.23% at 10 mu M, and meanwhile, zebra fish experiments show that intervention of the GPFPI effectively reverses accumulated optical density value reduction caused by dexamethasone, and the effect of inhibiting calcium absorption is achieved. Compared with a manufacturing module, the skull accumulative optical density value of a GPFPI (2-20 mu M) processing group is remarkably increased. It is shown that the synthetic peptide GPFPI can effectively promote Ca < 2 + > transfer and absorption, improve the osteoporosis symptom of zebra fish and increase deposition of calcium in bones.
Owner:HANGZHOU KANGYUAN FOOD SCI & TECH +1

Tortoise shell bioactive peptide as well as preparation method and application thereof

The invention discloses a tortoise shell bioactive peptide and a preparation method and application thereof.The tortoise shell bioactive peptide comprises one or more of EHTVVY, GPKKDQK, SPLSDVRGH, SENADKGALS and DPKMNGLK. The preparation method comprises the steps of preparation of tortoise shell protein hydrolysate, ultrafiltration separation, anion exchange resin separation, gel column separation, de novo sequencing analysis, molecular docking screening and solid-phase synthesis. The tortoise shell bioactive peptide can be applied to the fields of oxidation resistance and immunoregulation. The method disclosed by the invention is a separation, purification and identification technical method of the tortoise shell specific antioxidant polypeptide based on activity guidance, and has the advantages of clear components, clear activity, clear mechanism and the like; the obtained specific polypeptide has important significance for functional product development of polypeptide compounds with clear tortoise shell components.
Owner:益阳医学高等专科学校

Dihydroarteannuic acid dehydrogenase AaDHAADH mutant and application thereof

The invention discloses a dihydroarteannuic acid dehydrogenase AaDHAADH mutant and application thereof, the mutant is mutated on the basis of an amino acid sequence as shown in SEQ ID NO.1, and the mutation site is proline at the 26th site. According to the invention, a plurality of mutants are obtained from dihydroarteannuic acid dehydrogenase through molecular docking and site-directed mutagenesis technologies, directed optimization finds that the mutants have obviously improved catalytic activity compared with dihydroarteannuic acid dehydrogenase, and a faster and more efficient method is provided for large-scale production of a precursor compound DHAA of ART by adopting a synthetic biological method.
Owner:JINAN UNIVERSITY

Umami peptide prediction method and system based on deep learning

The invention discloses a deep learning-based umami peptide prediction method and system. The method comprises the following steps of S1, constructing a data set; s2, feature selection and processing; s3, constructing a Umami-Transform model: constructing the Umami-Transform model which comprises a feature processing and generating module, a sequence information processing module, a feature information processing module and a result output module; s4, model training; and S5, umami peptide prediction: inputting a peptide sequence to be detected into the trained Umami-Transformer model to obtain a probability prediction result that the peptide sequence is the umami peptide. According to the method, the Transform architecture and eight key physical and chemical characteristics are fused, so that peptide sequence information can be efficiently processed, and the prediction precision of the umami peptide is remarkably improved. All dipeptides to pentapeptides are screened by further combining with an exhaustion method, and an interaction mechanism between candidate peptides and the umami receptor T1R1 / T1R3 is analyzed through a molecular docking technology, so that the whole-process research from theoretical prediction to biological experimental verification is finally realized, and an innovative technical path is provided for efficient excavation and functional application of the umami peptides.
Owner:DALIAN POLYTECHNIC UNIVERSITY

Method for screening potential functional raw materials of cosmetics by establishing mathematical model based on molecular docking and physical and chemical properties of substances

The invention discloses a method for screening potential efficacy raw materials of cosmetics by establishing a mathematical model based on molecular docking and physical and chemical properties of substances, and the method comprises the following steps: S1, aiming at semi-flexible molecular docking of a specific efficacy target, including pretreatment and simulated docking of a compound ligand and a target receptor; s2, querying and selecting cosmetic application related indexes in a database, wherein the specific indexes are molecular weight, the number of hydrogen bond receptors and donors, fat-water distribution coefficient, topological polar surface area and skin permeability; and S3, alternative compound screening, including data preprocessing, definition of optimal / inferior values and median values, primary screening of principal component analysis, weight coefficient determination by an entropy weight method and Topsis comprehensive evaluation. According to the method, reasonable non-experimental type indexes are found, so that the screening efficiency is effectively improved, the cost is effectively reduced, the scientific large-batch raw material screening requirement can be met, and besides the screening purpose, the potential size of alternative compounds can be predicted and quantified.
Owner:ZHEJIANG LANSHU COSMETICS CO LTD

Tyrosinase inhibitory peptide from kelp as well as preparation method and application of tyrosinase inhibitory peptide

The invention discloses a tyrosinase inhibitory peptide from kelp as well as a preparation method and application of the tyrosinase inhibitory peptide. The preparation method comprises the following steps: pretreating kelp, fermenting the kelp by using lactobacillus plantarum, carrying out centrifugation, ultrafiltration and component identification on the obtained fermentation liquor to obtain the composition of kelp polypeptide, screening the tyrosinase inhibitory peptide through molecular docking, and finally carrying out solid-phase synthesis to obtain the tyrosinase inhibitory peptide prepared by the invention. The lactobacillus plantarum fermentation technology is simple and feasible, the production cost is low, equipment is easy to obtain, active ingredients in kelp can be released to the maximum extent, and the prepared polypeptide has the effect of inhibiting the activity of tyrosinase and can be used for developing a tyrosinase inhibitor.
Owner:JIMEI UNIV

Camel milk hypoglycemic peptide with DPP-IV inhibitory activity and GPR-40 agonistic activity and application of camel milk hypoglycemic peptide

The invention belongs to the technical field of dairy products, and particularly relates to preparation and application of camel milk hypoglycemic peptide with DPP-IV inhibitory activity and GPR-40 agonistic activity. According to the preparation method of the hypoglycemic peptide with camel milk as the raw material, camel milk endogenous peptide sequences capable of inhibiting DPP-IV and activating GPR-40 are obtained through screening with a molecular docking method, and the camel milk endogenous peptide sequences comprise AGM and KPAF. In vitro HepG2 hepatocytes prove that the camel milk endogenous peptide can improve insulin resistance uptake and synthesize glycogen by using glucose; the in-vivo level proves that the camel milk endogenous peptide has a certain improvement effect on insulin-resistant mice, and also has the effects of inhibiting serum DPP-IV and activating the expression of colon GPR-40. Therefore, the camel milk endogenous peptide disclosed by the invention has hypoglycemic activity, can relieve insulin resistance diseases, and provides a scientific basis for development of health-care foods and medicines with a blood sugar regulating effect and industrial production.
Owner:CHINA AGRI UNIV +1

Red kidney bean hypoglycemic active peptide and application thereof

The invention belongs to the technical field of plant active peptides, and particularly relates to a red kidney bean hypoglycemic active peptide and application thereof. The amino acid sequences of the hypoglycemic active peptide are FFGGPAF, SAKPFFSGL and PPGHPFVTF. The invention further discloses a preparation method of the hypoglycemic active peptide. FF, SL and PF for short. The polypeptide is prepared through enzymolysis of red kidney bean protein, and the polypeptide is identified by utilizing ultrafiltration separation and LC-MS / MS (Liquid Chromatography-Mass Spectrometry / Mass Spectrometry); the hypoglycemic active peptides which are high in hypoglycemic effect, free of toxicity, carcinogenicity and sensitization and capable of being absorbed by human intestinal tracts are screened out through a bioinformatics method and molecular docking, then the screened hypoglycemic active peptides and alpha-glucosidase are subjected to molecular docking, and finally three hypoglycemic active peptides FF, SL and PF are screened out. The invention finds that the hypoglycemic active peptides FF, SL and PF have high inhibitory activity on alpha-glucosidase, can obviously promote glucose consumption of insulin resistance model cells, and can be used for preparing hypoglycemic drugs, food and health care products.
Owner:SHANXI UNIV

Small-molecule active peptide with antioxidant and hypoglycemic effects, composition and application of small-molecule active peptide with antioxidant and hypoglycemic effects

The invention discloses a small-molecule active peptide with antioxidant and hypoglycemic effects, a composition and application, and belongs to the technical field of biological active peptides. The amino acid sequence of the small molecule active peptide with the antioxidant and blood sugar reducing effects is at least one of FSNAPRL, QFGRLY and SVPGHF. According to the invention, a plurality of micromolecular active peptides with antioxidant and hypoglycemic effects are extracted from walnut meal, the obtained peptide fragment sequence is subjected to molecular docking and chemical synthesis, and the antioxidant activity and hypoglycemic activity of a single peptide fragment and a compound peptide fragment of the synthesized peptide fragment are verified. The active peptide and the compound peptide fragment thereof have good DPPH and ABTS clearance rate and alpha-glucosidase and alpha-amylase inhibition ability, so that the active peptide and the compound peptide fragment thereof have good application prospects in preparation of products with antioxidant and hypoglycemic effects, and a foundation is laid for comprehensive utilization of walnut meal byproducts and promotion of research, development and application of functional active peptides.
Owner:ANHUI SEMNL BIOTECHNOLOGY CO LTD

Improved mutant for catalytic synthesis of icariside D2 glycosyltransferase

According to the invention, a glycosyl transferase mutant derived from Bacillus licheniformis ZSP01 is used as a research object, AlphaFold 2 is used for constructing a three-dimensional structure of a protein, then technologies such as molecular docking and molecular dynamics simulation are used for analyzing amino acids far away from a catalytic center in glycosyl transferase, site-directed mutagenesis is carried out on the amino acids, and the glycosyl transferase is obtained. The activity of the mutant for catalytically synthesizing the icariside D2 glycosyltransferase is improved.
Owner:NANJING TECH UNIV

Preparation method and application of novel glycoside component in eupatorium chinense

ActiveCN119529004AOrganic active ingredientsSugar derivativesDiseaseProtein Tyrosine Phosphatase 1B
The invention discloses a preparation method and application of a novel glycoside component in eupatorium chinense. The compound is separated from an eupatorium chinense extract. The eupatorium chinense root extract is separated by using an extraction method, macroporous adsorption resin impurity removal, HW-40F gel column chromatography, high performance liquid chromatography and other methods to obtain a new glycoside compound. The inhibitory activity of the separated compound on diabetes related targets alpha-glucosidase and protein tyrosine phosphatase 1B (PTP1B) is tested, the experimental result shows that the compound has good inhibitory activity on two enzymes, and the molecular docking experiment also shows that the compound has good inhibitory activity on the two enzymes. The compound has good binding energy with two target protein alpha-glucosidase and protein tyrosine phosphatase 1B. Therefore, the compound can be used for preparing medicines for preventing, delaying or treating alpha-glucosidase or PTP1B-mediated diseases, especially type II diabetes and obesity, or can be used as a lead compound of the medicines.
Owner:CHINA THREE GORGES UNIV

Preparation method and application of novel benzofuran component in eupatorium chinense

ActiveCN118994069AOrganic active ingredientsOrganic chemistryDiseaseProtein Tyrosine Phosphatase 1B
The invention discloses a preparation method and application of a novel benzofuran component in eupatorium chinense. The compound is obtained by being separated from an extraction part of the eupatorium chinense. The eupatorium chinense root extract is separated by using an extraction method, macroporous adsorption resin impurity removal, HW-40F gel column chromatography, high performance liquid chromatography and other methods to obtain a new benzofuran compound. The inhibitory activity of the separated compound on diabetes related targets alpha-glucosidase and protein tyrosine phosphatase 1B (PTP1B) is tested, the experimental result shows that the compound has good inhibitory activity on two enzymes, and the molecular docking experiment also shows that the compound has good inhibitory activity on the two enzymes. The compound has good binding energy with two target proteins alpha-glucosidase and protein tyrosine phosphatase 1B, so that the compound can be used for preparing drugs for preventing, delaying or treating alpha-glucosidase or PTP1B-mediated diseases, especially type II diabetes and obesity, or can be used as a lead compound of the drugs.
Owner:CHINA THREE GORGES UNIV

BHET hydrolase designed based on inverse folding algorithm and preparation method thereof

The invention discloses a BHET hydrolase designed based on an inverse folding algorithm and a preparation method of the BHET hydrolase, and relates to the technical field of biology. The preparation method comprises the following steps: selecting polyester hydrolase PHL7, learning a protein crystal structure by using a deep learning algorithm Protein MPNN, carrying out three-dimensional structure modeling by using Esmfold, carrying out molecular docking on candidate protein and BHET, carrying out molecular dynamics simulation, and screening out protein which is well combined with a substrate; performing expression and purification; the invention further discloses the application of the BHET hydrolase in hydrolysis of BHET. Through the screening process, the BHET hydrolase can be simply, rapidly and efficiently screened from the candidate sequences generated in a large scale, and the source of the BHET hydrolase is expanded.
Owner:SHANGHAI JIAOTONG UNIV

Novel benzofuran component in eupatorium chinense and application of benzofuran component in anti-inflammatory activity

The invention discloses a novel benzofuran component in eupatorium chinense and application of the benzofuran component in anti-inflammatory activity. The obtained compound is separated from an eupatorium chinense extract. The eupatorium chinense root extract is separated by using an extraction method, macroporous adsorption resin impurity removal, Sephadex LH-20 gel column chromatography, high performance liquid chromatography and other methods. According to the present invention, all the separated compounds and the analogues thereof have good inhibition activity on target cyclooxygenase-2 of inflammation-related diseases, and have good inhibition activity on COX-2 enzyme, and the molecular docking experiment results show that the compounds and the target proteins have good binding energy. Therefore, the compound can be used for preparing drugs for treating inflammatory related diseases, or anti-inflammatory and analgesic drugs, or tumor drugs by inhibiting COX-2 enzyme, such as drugs for rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, Alzheimer's disease and the like, and related natural lead compounds are provided.
Owner:CHINA THREE GORGES UNIV

Peptiomics-based computer-aided rapid screening method, collagen antifreeze peptide and application thereof

ActiveCN119339786ABiostatisticsProteomicsAntifreeze PeptidesCollagenan
The invention discloses a peptidomics-based computer-aided rapid screening method, collagen antifreeze peptide and application thereof, and relates to the fields of food biotechnology and bioinformatics. The amino acid sequence of the collagen antifreeze peptide is as shown in any one of SEQ ID NO.1-5. The invention provides a computer-aided antifreeze peptide rapid screening method based on peptiomics, which comprises the following steps: performing peptiomics analysis on a cod collagen hydrolysate containing a large amount of polypeptide, and screening the antifreeze peptide according to physicochemical properties, amino acid composition of a primary structure and a molecular docking result of the cod collagen hydrolysate. The interaction capability of the cod collagen hydrolysate and the ice crystals is scored in multiple aspects, so that the antifreeze peptide with strong interaction capability with the ice crystals is rapidly screened. The antifreeze peptide provided by the invention can form a plurality of hydrogen bonds with ice crystals, has extremely strong action capacity with the ice crystals, can be used for preparing an antifreeze agent, and is further applied to frozen surimi products.
Owner:SHENZHEN INST OF GUANGDONG OCEAN UNIV

Sea cucumber gonad-derived anti-inflammatory peptide as well as preparation method and application thereof

The invention belongs to the technical field of food biology, and particularly relates to sea cucumber gonad-derived anti-inflammatory peptide as well as a preparation method and application thereof. The anti-inflammatory peptide is obtained by performing enzymolysis and molecular docking screening on sexual glands of sea cucumbers, and comprises at least one of peptides with amino acid sequences as shown in SEQ.ID.NO.1-3. Experiments prove that the anti-inflammatory peptide has high anti-inflammatory activity, provides a basis for preparing functional food from natural food sources, and has important significance for development of novel anti-inflammatory products.
Owner:HAINAN RUANFU TECHNOLOGY GROUP CO LTD

Virtual screening method of xanthine oxidase inhibitory peptide

The invention discloses a virtual screening method of xanthine oxidase inhibitory peptides, and belongs to the technical field of bioactive peptide screening. In the preliminary stage of virtual screening, 41 combinations of 6 enzymes are used, more than two millions of peptide fragments are released from pig viscera protein, 14544 peptide fragments are finally reserved by an activity probability prediction tool, and the peptide fragment with the length of 3-6 amino acid residues has the advantages of being rich in proportion and higher in activity potential and is reserved. Peptide fragments with four lengths reserved by virtual screening and xanthine oxidase are subjected to molecular docking to obtain docking binding energy, a database is formed, the inhibitory activity has normal distribution, and no gap exists; when the prediction model is established, 32 amino acid descriptors are adopted to carry out structural characterization on the xanthine oxidase inhibitory peptide of each length, six machine learning methods are adopted to carry out modeling to obtain an optimal model, and the xanthine oxidase inhibitory peptide is predicted by the optimal model to obtain the high-activity xanthine oxidase inhibitory peptide.
Owner:SICHUAN AGRI UNIV

Walnut peptide with neuroprotection function as well as preparation method and application thereof

The invention relates to the technical field of bioactive peptides, and discloses a walnut peptide with a neuroprotection function and a preparation method and application thereof, and predicts that a batch of small molecular walnut peptides have the neuroprotection function through enzymolysis of natural walnut protein, molecular weight screening and molecular docking. Experiments prove that the walnut peptide disclosed by the invention has a nerve protection function: the cell activity of nerve cells is improved, and the walnut peptide plays a role in preventing neurodegenerative diseases and other nerve-related diseases; the toxic effect of oxidative damage on nerve cells is relieved, nerve cell apoptosis is inhibited, the cell viability of the nerve cells is improved, and the function of treating nerve injury related diseases is achieved; the compound can be used for improving the activity of nerve cells, relieving oxidative damage of the nerve cells, adjusting the protein level of nerve damage related pathways, preparing related drugs for reducing blood pressure or resisting senile dementia or tumors and the like, and has a wide application prospect.
Owner:ZHEJIANG UNIV OF TECH SHAOXING BIOMEDICAL RES INST CO LTD

Raw amylolytic enzyme mutant as well as expression strain and application thereof

The invention discloses a raw amylolytic enzyme mutant as well as an expression strain and application thereof. According to the present invention, alpha-amylase AmyZ1 from Pontibacillus sp.ZY is adopted as a starting enzyme, a substrate binding subsite is determined through molecular docking, and site-directed mutagenesis is performed on residues at a + 1 site and at a 199 site so as to obtain the mutant enzyme L199F with high glucose yield; when the mutant enzyme is used in an industrial sugar manufacturing process, corn raw starch is used as a substrate, and the DE value can reach 35% after liquefaction for 2 h and is 1.44 times that of a starting enzyme; after saccharification for 18 hours, the DE value can reach 99%, which is 5 hours earlier than that of the starting enzyme. Therefore, the mutant enzyme has relatively high potential application value in the field of sugar industry taking corn raw starch as a substrate.
Owner:ANHUI UNIV